Incidence and Survival of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Cirrhosis Who Were Treated with and without Metformin

PURPOSE: To evaluate metformin’s benefit on the incidence and survival of hepatocellular carcinoma (HCC) in cirrhosis with type 2 diabetes mellitus (T2DM) patients. PATIENTS AND METHODS: We conducted a retrospective study from 2006 to 2019. The patients were assigned to metformin exposure if they ad...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes Metab Syndr Obes
Main Authors: Tangjarusritaratorn, Thanida, Tangjittipokin, Watip, Kunavisarut, Tada
Format: Artigo
Language:Inglês
Published: Dove 2021
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8043797/
https://ncbi.nlm.nih.gov/pubmed/33859487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S295753
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items